RMB Capital Management LLC cut its holdings in CME Group Inc (NASDAQ:CME) by 0.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 58,655 shares of the financial services provider’s stock after selling 306 shares during the period. RMB Capital Management LLC’s holdings in CME Group were worth $10,142,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in CME. Alliancebernstein L.P. lifted its stake in CME Group by 0.5% in the 4th quarter. Alliancebernstein L.P. now owns 1,582,495 shares of the financial services provider’s stock worth $317,638,000 after purchasing an additional 8,234 shares in the last quarter. Daiwa Securities Group Inc. lifted its stake in CME Group by 28.0% in the 4th quarter. Daiwa Securities Group Inc. now owns 24,272 shares of the financial services provider’s stock worth $4,872,000 after purchasing an additional 5,313 shares in the last quarter. Chicago Partners Investment Group LLC lifted its stake in CME Group by 86.5% in the 4th quarter. Chicago Partners Investment Group LLC now owns 5,449 shares of the financial services provider’s stock worth $1,129,000 after purchasing an additional 2,527 shares in the last quarter. M&G Investment Management Ltd. purchased a new stake in CME Group in the 4th quarter worth approximately $7,293,000. Finally, Conning Inc. lifted its stake in CME Group by 1.0% in the 4th quarter. Conning Inc. now owns 5,120 shares of the financial services provider’s stock worth $1,028,000 after purchasing an additional 50 shares in the last quarter. 85.08% of the stock is owned by institutional investors.
Several analysts have issued reports on the stock. Bank of America lowered their target price on shares of CME Group from $216.00 to $168.00 and set a “neutral” rating on the stock in a research note on Monday, March 23rd. UBS Group raised their price objective on shares of CME Group from $222.00 to $225.00 and gave the company a “buy” rating in a research report on Thursday, April 30th. Raymond James upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $194.00 price objective on the stock in a research report on Monday, March 30th. Credit Suisse Group restated a “hold” rating and set a $190.00 price objective on shares of CME Group in a research report on Tuesday, April 28th. Finally, Wells Fargo & Co raised their price objective on shares of CME Group from $180.00 to $186.00 and gave the company an “equal weight” rating in a research report on Thursday, April 30th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $193.67.
Shares of CME stock traded up $0.62 on Friday, hitting $178.80. 993,082 shares of the company’s stock traded hands, compared to its average volume of 1,745,097. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.01 and a current ratio of 1.01. CME Group Inc has a one year low of $131.80 and a one year high of $225.36. The company’s fifty day simple moving average is $181.12 and its 200 day simple moving average is $196.24. The stock has a market capitalization of $63.89 billion, a price-to-earnings ratio of 26.85, a P/E/G ratio of 4.28 and a beta of 0.32.
CME Group (NASDAQ:CME) last released its earnings results on Wednesday, April 29th. The financial services provider reported $2.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.23 by $0.10. The company had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.48 billion. CME Group had a net margin of 45.79% and a return on equity of 10.15%. The firm’s quarterly revenue was up 29.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.62 EPS. As a group, sell-side analysts anticipate that CME Group Inc will post 7.73 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Wednesday, June 10th will be issued a $0.85 dividend. This represents a $3.40 dividend on an annualized basis and a yield of 1.90%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is presently 50.00%.
In other CME Group news, insider Julie Winkler sold 5,620 shares of the firm’s stock in a transaction on Monday, February 24th. The shares were sold at an average price of $210.97, for a total value of $1,185,651.40. Following the sale, the insider now owns 25,114 shares of the company’s stock, valued at approximately $5,298,300.58. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Julie Holzrichter sold 3,061 shares of CME Group stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $203.37, for a total transaction of $622,515.57. Following the sale, the chief operating officer now directly owns 37,284 shares in the company, valued at approximately $7,582,447.08. The disclosure for this sale can be found here. In the last three months, insiders sold 11,692 shares of company stock worth $2,350,147. Insiders own 1.20% of the company’s stock.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Story: What is the NASDAQ Stock Market?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.